MedTrace Logo

Adaptive Radiotherapy in Patients With Gynecological Tumors

NCT06230549 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2024-02-09

No results posted yet for this study

Summary

Prospective randomized evaluation of adaptive radiotherapy in the definitive radiotherapy of locally advanced gynecologic carcinoma (e.g. cervical carcinoma, endometrial carcinoma, vaginal carcinoma), in the postoperative situation or first series of external beam radiotherapy and in patients in whom radical surgery or HDR brachytherapy as dose boost is not an option.

Conditions

  • Gynecological Tumor
  • Adaptive Radiotherapy
  • Radiation
  • Curative Treatment
  • Optimization
  • Adaptive Radiation Therapy
  • Image Guided Radiotherapy
  • Cervical Carcinoma

Interventions

RADIATION

Adaptive Radiotherapy

Adaptive Radiotherapy, online onboard adaptation of dose distribution with a specialist radiation oncologist and a medical physicist

Sponsors & Collaborators

  • University Hospital, Essen

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-15
Primary Completion
2024-12-15
Completion
2026-12-15
FDA Device
Yes

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06230549 on ClinicalTrials.gov